A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma.
Blood
; 136(21): 2401-2409, 2020 11 19.
Article
in En
| MEDLINE
| ID: mdl-32730586
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hodgkin Disease
/
Antineoplastic Combined Chemotherapy Protocols
/
Receptors, IgG
/
Ki-1 Antigen
/
Immunotherapy
/
Antigens, Neoplasm
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Blood
Year:
2020
Document type:
Article